Cleared Special

K221487 - NEOVEIL Staple Line Reinforcement (FDA 510(k) Clearance)

Aug 2022
Decision
95d
Days
Class 2
Risk

K221487 is an FDA 510(k) clearance for the NEOVEIL Staple Line Reinforcement. This device is classified as a Mesh, Surgical, Absorbable, Staple Line Reinforcement (Class II - Special Controls, product code OXC).

Submitted by Gunze Limited (Ayabe, Kyoto, JP). The FDA issued a Cleared decision on August 26, 2022, 95 days after receiving the submission on May 23, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.3300. For Reinforcement Of Soft Tissue Where Weakness Exists During Staple Line Reinforcement Procedures..

Submission Details

510(k) Number K221487 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2022
Decision Date August 26, 2022
Days to Decision 95 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OXC - Mesh, Surgical, Absorbable, Staple Line Reinforcement
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3300
Definition For Reinforcement Of Soft Tissue Where Weakness Exists During Staple Line Reinforcement Procedures.